These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25133049)

  • 21. Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.
    Lee AJ; Maddix DS
    Ann Pharmacother; 2001 Jan; 35(1):26-31. PubMed ID: 11197581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety of statins in clinical practice.
    Armitage J
    Lancet; 2007 Nov; 370(9601):1781-90. PubMed ID: 17559928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-induced myotoxicity: pharmacokinetic differences among statins and the risk of rhabdomyolysis, with particular reference to pitavastatin.
    Catapano AL
    Curr Vasc Pharmacol; 2012 Mar; 10(2):257-67. PubMed ID: 22022768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal rhabdomyolysis in a patient with liver cirrhosis after switching from simvastatin to fluvastatin.
    Baek SD; Jang SJ; Park SE; Ok TJ; Leem J; Lee HS; Park SJ; Kim TH
    J Korean Med Sci; 2011 Dec; 26(12):1634-7. PubMed ID: 22148003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhabdomyolysis associated with concomitant use of atorvastatin and cyclosporine.
    Maltz HC; Balog DL; Cheigh JS
    Ann Pharmacother; 1999 Nov; 33(11):1176-9. PubMed ID: 10573315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased dosage of cyclosporine induces myopathy with increased seru creatine kinase in an elderly patient on chronic statin therapy.
    Mo L; He J; Yue Q; Dong B; Huang X
    J Clin Pharm Ther; 2015 Apr; 40(2):245-8. PubMed ID: 25512016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid].
    Gabignon C; Zeller V; Le Guyader N; Desplaces N; Lidove O; Ziza JM
    Rev Med Interne; 2013 Jan; 34(1):39-41. PubMed ID: 23102978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levofloxacin-induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review.
    Bouchard J; De La Pena N; Oleksiuk LM
    J Clin Pharm Ther; 2019 Dec; 44(6):966-969. PubMed ID: 31407828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins).
    Igel M; Sudhop T; von Bergmann K
    Eur J Clin Pharmacol; 2001 Aug; 57(5):357-64. PubMed ID: 11599653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhabdomyolysis in a patient treated with colchicine and atorvastatin.
    Tufan A; Dede DS; Cavus S; Altintas ND; Iskit AB; Topeli A
    Ann Pharmacother; 2006; 40(7-8):1466-9. PubMed ID: 16772404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety considerations for statins.
    Bolego C; Baetta R; Bellosta S; Corsini A; Paoletti R
    Curr Opin Lipidol; 2002 Dec; 13(6):637-44. PubMed ID: 12441888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statin-Associated Necrotizing Myopathy Leading to Acute Kidney Injury: A Case Report.
    Petreski T; Piko N; Petrijan T; Dvoršak B; Hojs R; Bevc S
    Case Rep Nephrol Dial; 2021; 11(2):129-135. PubMed ID: 34250030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone.
    Elazzazy S; Eziada SS; Zaidan M
    Int Med Case Rep J; 2012; 5():59-61. PubMed ID: 23754925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
    Bastida C; Also MA; Pericas JM; Letang E; Tuset M; Miró JM
    Enferm Infecc Microbiol Clin; 2014 Nov; 32(9):579-82. PubMed ID: 24913991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyolysis with simvastatin.
    Patel BR; Choudhury M
    BMJ Case Rep; 2011 Jan; 2011():. PubMed ID: 22715232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhabdomyolysis and HMG-CoA reductase inhibitors.
    Omar MA; Wilson JP; Cox TS
    Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin safety: a systematic review.
    Law M; Rudnicka AR
    Am J Cardiol; 2006 Apr; 97(8A):52C-60C. PubMed ID: 16581329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.